Suppr超能文献

基于超高效液相色谱-四极杆飞行时间串联质谱、网络药理学及实验验证探索刺五加片治疗失眠的潜在机制

Exploring potential mechanism of ciwujia tablets for insomnia by UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation.

作者信息

Liu Hongda, Yang Le, Wan Chunlei, Li Zhineng, Yan Guangli, Han Ying, Sun Hui, Wang Xijun

机构信息

National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacochemistry, Metabolomics Laboratory, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin, China.

State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

出版信息

Front Pharmacol. 2022 Aug 30;13:990996. doi: 10.3389/fphar.2022.990996. eCollection 2022.

Abstract

Insomnia, whether chronic or intermittent, is a common central nervous system disease. Ciwujia Tablet (CWT) is a well-known traditional Chinese medicine (TCM) made from the extract of (Rupr. & Maxim.) Maxim. This medication is commonly used for treating insomnia in China, but the lack of in-depth research focused on the chemical ingredients of CWT creates a gap in knowledge regarding its effective constituents against insomnia. Considering that the therapeutic material basis, targets, and pathways related to this drug have not been fully investigated by scholars in the field, the focus of this study is on identifying the chemical ingredients or structural characteristics of CWT by the UPLC-Q-TOF-MS/MS technique. Besides, concepts of network pharmacology were also used to investigate the targets and pathways of CWT. An insomnia rat model was established by intraperitoneal injection of p-chlorophenylalanine, and the results were verified through various experiments. A total of 46 ingredients were identified in CWT, such as eleutheroside B, eleutheroside E, isofraxidin, and chlorogenic acid. Among them, 17 ingredients with good solubility, favorable gastrointestinal absorption, and high bioavailability were selected for network pharmacological analysis. It was concluded that CWT participated in the regulation of neurotransmitter levels, modulation of ion transport, neurotransmitter receptor activity, synaptic transmission, dopaminergic transmission and other essential processes. Results from the animal experiments showed that CWT can increase the content of inhibitory neurotransmitters 5-HT and GABA in the brain, reduce the synthesis of excitatory escalating transmitters DA and NE, shorten the sleep latency and prolong the sleep duration of insomnia rats. Furthermore, CWT could significantly alleviate the symptoms of insomnia in model rats. Identifying the chemical ingredients of CWT in this experiment is of great significance for exploring its potential curative effects, which provides a solid basis for further understanding the therapeutic value of this medication.

摘要

失眠,无论是慢性还是间歇性的,都是一种常见的中枢神经系统疾病。刺五加片(CWT)是一种著名的中药,由刺五加(Rupr. & Maxim.)Maxim.的提取物制成。这种药物在中国常用于治疗失眠,但缺乏对刺五加片化学成分的深入研究,这在其抗失眠有效成分的知识方面存在空白。鉴于该药物的治疗物质基础、靶点和途径尚未得到该领域学者的充分研究,本研究的重点是通过超高效液相色谱-四极杆飞行时间串联质谱(UPLC-Q-TOF-MS/MS)技术鉴定刺五加片的化学成分或结构特征。此外,还运用网络药理学概念来研究刺五加片的靶点和途径。通过腹腔注射对氯苯丙氨酸建立失眠大鼠模型,并通过各种实验进行验证。在刺五加片中总共鉴定出46种成分,如刺五加苷B、刺五加苷E、异嗪皮啶和绿原酸。其中,选择了17种具有良好溶解性、有利的胃肠道吸收和高生物利用度的成分进行网络药理学分析得出,刺五加片参与了神经递质水平的调节、离子转运的调节、神经递质受体活性、突触传递、多巴胺能传递等重要过程。动物实验结果表明,刺五加片可以增加大脑中抑制性神经递质5-羟色胺(5-HT)和γ-氨基丁酸(GABA)的含量,减少兴奋性神经递质多巴胺(DA)和去甲肾上腺素(NE)的合成,缩短失眠大鼠的睡眠潜伏期并延长睡眠时间。此外,刺五加片可以显著减轻模型大鼠的失眠症状。本实验鉴定刺五加片的化学成分对于探索其潜在疗效具有重要意义,为进一步了解该药物的治疗价值提供了坚实基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c6/9468710/1b43f69ef296/fphar-13-990996-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验